BioStem Technologies, Inc
Price
From the filings
Figures
- Revenue
- $47.5Mlast 12 months
- Net income
- −$6.6Mlast 12 months
- Operating cash flow
- $9.9Mlast 12 months
- Cash and equivalents
- $7.0Mat the last balance sheet
- Total debt
- $0.00at the last balance sheet
- Shares outstanding
- 17.8M shareson issue